Peter Winkle

1.7k citations

42 papers · 1.2k indexed · h-index 18

Impact in

Anesthesiology and Pain Medicine top 0.5%
- Anesthesia and Sedative Agents
Critical Care and Intensive Care Medicine top 2%
- Intensive Care Unit Cognitive Disorders

Papers in ⓘ

Anesthesiology and Pain Medicine 7
- Anesthesia and Sedative Agents 5
Gastroenterology 6
- Celiac Disease Research and Management 4

Co-authors: Keith M. Borkett (5 shared papers)Howard I. Schwartz (3 shared papers)Karin Wilhelm-Ogunbiyi (4 shared papers)Dennis Riff (4 shared papers)Daniel J. Pambianco (4 shared papers)James P. Lees (2 shared papers)Timothy Melson (2 shared papers)Thomas Stöhr (1 shared paper)
Journals: Gastroenterology (3 papers)Clinical and Translational Science (2 papers)Journal of Pain Research (2 papers)Human Vaccines & Immunotherapeutics (2 papers)Annals of the Rheumatic Diseases (2 papers)
Partner nations: United States Switzerland Japan

In The Last Decade

Peter Winkle

41 papers receiving 1.1k citations

Peers

Countries citing papers authored by Peter Winkle

Since Specialization

Citations

This map shows the geographic impact of Peter Winkle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Winkle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Winkle more than expected).

Fields of papers citing papers by Peter Winkle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Winkle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Winkle. The network helps show where Peter Winkle may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Winkle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Winkle Line = papers co-authored together Peter Winkle links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy Anesthesia & Analgesia ·Keith M. Borkett, Dennis Riff, Howard I. Schwartz, Peter Winkle, Daniel J. Pambianco, James P. Lees, Karin Wilhelm-Ogunbiyi	2014	153
2	A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy Gastrointestinal Endoscopy ·Daniel J. Pambianco, Keith M. Borkett, Dennis Riff, Peter Winkle, Howard I. Schwartz, Timothy Melson, Karin Wilhelm-Ogunbiyi	2015	125
3	Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment British Journal of Anaesthesia ·Thomas Stöhr, Pieter Colin, Joachim Ossig, Marija Pesic, Keith M. Borkett, Peter Winkle, Michel Struys, Frank Schippers	2021	123
4	BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial Journal of Bone and Mineral Research ·Francis H. Glorieux, Jean‐Pierre Devogelaer, Michaela Durigova, Stefan Goemaere, Sarah Hemsley, Franz Jakob, U. Junker, Jon Ruckle, Lothar Seefried, Peter Winkle	2017	107
5	The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF‐06700841) in Healthy Subjects and Patients With Plaque Psoriasis The Journal of Clinical Pharmacology ·Christopher Banfield, Matthew Scaramozza, Weidong Zhang, Elizabeth Kieras, Karen Page, Andrew Fensome, Michael S. Vincent, Martin E. Dowty, Kosalaram Goteti, Peter Winkle, Elena Peeva	2017	71
6	The Effect of Medical Nutrition Therapy by a Registered Dietitian Nutritionist in Patients with Prediabetes Participating in a Randomized Controlled Clinical Research Trial Journal of the Academy of Nutrition and Dietetics ·Anna Parker, Laura Byham‐Gray, Robert Denmark, Peter Winkle	2014	55
7	Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease Gastroenterology ·Ingrid Swanson Pultz, Malcolm Hill, Joanne M. Vitanza, Clancey Wolf, Lasse Saaby, Tina Liu, Peter Winkle, Daniel A. Leffler	2021	52
8	Biliary Interleukin-6 and Tumor Necrosis Factor-α in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography Digestive Diseases and Sciences ·Hugo R. Rosen, Peter Winkle, Bradley J. Kendall, David L. Diehl	1997	45
9	HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study Hernia ·Eugene R. Viscusi, Harold S. Minkowitz, Peter Winkle, Sonia Ramamoorthy, Jia Hu, Neil Singla	2019	39
10	Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study RMD Open ·R. Fleischmann, Peter Winkle, Jeffrey N. Miner, Xiaohong Yan, Liz Hicks, Shakti Valdez, Jesse Hall, Sha Liu, Zancong Shen, Michael Gillen, Martha Hernandez‐Illas	2018	37
11	Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial The Lancet. Gastroenterology & hepatology ·Joseph A. Murray, Dina Wassaf, Karen Dunn, Samir Arora, Peter Winkle, Helen Stacey, Simon Cooper, Kaela E. Goldstein, Rajesh V. Manchanda, Stephan Kontos, Kristie M. Grebe	2023	34
12	A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumab Cancer Chemotherapy and Pharmacology ·Francisco J. Esteva, Justin Stebbing, Rebecca N. Wood-Horrall, Peter Winkle, Sungyoung Lee, Sang Joon Lee	2018	27
13	Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study Clinical Therapeutics ·Winnie Sohn, Peter Winkle, Joel Neutel, You Wu, Freeman Jabari, Caitlin Terrio, Tracy Varrieur, Jingying Wang, Jennifer Hellawell	2022	25
14	Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial Human Vaccines & Immunotherapeutics ·M. Turner, Athanasia Papadimitriou, Peter Winkle, Nathan Segall, Michael C. Levin, Matthew W. Doust, Casey Johnson, Gregg Lucksinger, Carlos Fierro, Paul Pickrell, Marsha G. Raanan, Vianney Tricou, Astrid Borkowski, Derek Wallace	2020	24
15	Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study Clinical and Translational Science ·Ravi Shankar Prasad Singh, Vivek Pradhan, Erika Roberts, Matthew Scaramozza, Elizabeth Kieras, Jeremy D. Gale, Elena Peeva, Michael S. Vincent, Anindita Banerjee, Andrew Fensome, Martin E. Dowty, Peter Winkle, Christopher Tehlirian	2020	24
16	An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life Human Vaccines & Immunotherapeutics ·Sanjay S. Patel, Peter Winkle, Alice Faccin, Francesco Nordio, Inge Lefevre, Claudia M. Galindo	2023	20
17	Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects Journal of Nephrology ·Edward Chong, Veena Kalia, S.K. Willsie, Peter Winkle	2014	20
18	Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial Pain Practice ·Eugene R. Viscusi, Oscar A. de León-Casasola, Jesús Cebrecos, Adam Jacobs, Adelaida Morte, Esther Ortiz, Mariano Sust, Anna Vaqué, Ira J. Gottlieb, Stephen Daniels, Joseph Gimbel, Derek Muse, Peter Winkle, Michael E. Kuss, Sebastián Videla, Neus Gascón, Carlos R. Plata‐Saláman	2022	18
19	A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients Cardiovascular Drugs and Therapy ·Peter Winkle, Steven R. Goldsmith, Michael J. Koren, Serge Lepage, Jennifer Hellawell, Ashit Trivedi, Kate Tsirtsonis, Siddique Abbasi, Allegra Kaufman, Richard W. Troughton, Adriaan A. Voors, Jean‐Sébastien Hulot, Erwan Donal, Navid Kazemi, Joel Neutel	2022	16
20	Investigation of the Interactions between Methadone and Elvitegravir-Cobicistat in Subjects Receiving Chronic Methadone Maintenance Antimicrobial Agents and Chemotherapy ·R. Douglas Bruce, Peter Winkle, Joseph M. Custodio, X. Wei, Martin S. Rhee, Brian P. Kearney, Srini Ramanathan, Gerald Friedland	2013	16

About Peter Winkle

Peter Winkle is a scholar working on Anesthesiology and Pain Medicine, Gastroenterology, Nephrology, Critical Care and Intensive Care Medicine and Small Animals, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Anesthesia and Sedative Agents (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Celiac Disease Research and Management (4 papers), Gout, Hyperuricemia, Uric Acid (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Anesthesia and Pain Management (4 papers), Mosquito-borne diseases and control (4 papers) and Intensive Care Unit Cognitive Disorders (3 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (434 citations), Critical Care and Intensive Care Medicine (214 citations), Developmental Neuroscience (132 citations), Gastroenterology (88 citations) and Nephrology (68 citations). Peter Winkle has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Keith M. Borkett, Howard I. Schwartz, Karin Wilhelm-Ogunbiyi, Dennis Riff, Daniel J. Pambianco, James P. Lees, Timothy Melson, Thomas Stöhr, Marija Pesic and Pieter Colin. Their work appears in journals such as Gastroenterology, Clinical and Translational Science, Journal of Pain Research, Human Vaccines & Immunotherapeutics and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact